Dubow Adam 4
4 · Day One Biopharmaceuticals, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Day One (DAWN) Gen Counsel Adam Dubow Receives Award
What Happened
Adam Dubow, General Counsel & Secretary of Day One Biopharmaceuticals (DAWN), received two equity awards on 2026-01-30: a grant of 105,000 derivative awards (stock options) and a grant of 70,000 Restricted Stock Units (RSUs). Both grants are reported with a $0.00 acquisition price (typical for compensation awards); no shares were sold. These are compensation/retention awards rather than open-market purchases or sales.
Key Details
- Transaction date: 2026-01-30; reported to the SEC the same day (timely filing).
- 105,000 derivative awards (options) reported at $0.00; vesting: 1/48th monthly beginning Feb 28, 2026 (4‑year monthly schedule). (Footnote F1)
- 70,000 RSUs reported at $0.00; each RSU converts to one share at settlement; vesting: 1/16th quarterly on Feb 15, May 15, Aug 15 and Nov 15 (4‑year quarterly schedule). (Footnotes F2–F4)
- RSUs do not expire; they either vest or are canceled prior to vesting (F4).
- Shares owned after the transaction are not specified in the provided filing excerpt.
Context
- The 105,000 derivative award appears to be stock options (right to buy shares per vest schedule); the 70,000 RSUs are a contingent right to receive shares when they vest and settle. Neither award conveys immediately tradable stock or immediate cash proceeds.
- Such grants are commonly part of executive compensation and retention packages and do not by themselves indicate buying or selling intent in the open market.
Insider Transaction Report
Form 4
Dubow Adam
Gen Counsel & Secretary
Transactions
- Award
Stock Option (right to buy Common Stock)
[F1]2026-01-30+105,000→ 105,000 totalExercise: $11.16Exp: 2036-01-29→ Common Stock (105,000 underlying) - Award
Restricted Stock Units
[F2][F3][F4]2026-01-30+70,000→ 70,000 total→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]The option vests as to 1/48th of the total shares monthly, commencing February 28, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F4]RSUs do not expire; they either vest or are canceled prior to the vesting date.
Signature
/s/ Charles N. York II, as Attorney-in-Fact|2026-01-30